CN116172196A - A health drink containing broad bean (with pods) extract - Google Patents
A health drink containing broad bean (with pods) extract Download PDFInfo
- Publication number
- CN116172196A CN116172196A CN202111438368.2A CN202111438368A CN116172196A CN 116172196 A CN116172196 A CN 116172196A CN 202111438368 A CN202111438368 A CN 202111438368A CN 116172196 A CN116172196 A CN 116172196A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- pods
- broad bean
- health drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 38
- 240000006677 Vicia faba Species 0.000 title claims abstract description 29
- 235000010749 Vicia faba Nutrition 0.000 title claims abstract description 29
- 235000002098 Vicia faba var. major Nutrition 0.000 title claims abstract description 29
- 241000196324 Embryophyta Species 0.000 claims abstract description 27
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 206010034010 Parkinsonism Diseases 0.000 claims abstract description 7
- 235000006533 astragalus Nutrition 0.000 claims abstract description 6
- 241001061264 Astragalus Species 0.000 claims abstract description 5
- 210000004233 talus Anatomy 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract 3
- 229940010454 licorice Drugs 0.000 claims abstract 3
- 240000002045 Guettarda speciosa Species 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 235000013361 beverage Nutrition 0.000 claims description 8
- 241000305491 Gastrodia elata Species 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 3
- 239000000619 acesulfame-K Substances 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- 238000010411 cooking Methods 0.000 claims 3
- 241000202807 Glycyrrhiza Species 0.000 claims 2
- 244000061520 Angelica archangelica Species 0.000 claims 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 239000009636 Huang Qi Substances 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 229940001584 sodium metabisulfite Drugs 0.000 claims 1
- 229940069765 bean extract Drugs 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 19
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 11
- 206010044565 Tremor Diseases 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 239000007928 intraperitoneal injection Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- PLRACCBDVIHHLZ-UHFFFAOYSA-N 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Chemical compound C1N(C)CCC(C=2C=CC=CC=2)=C1 PLRACCBDVIHHLZ-UHFFFAOYSA-N 0.000 description 5
- 208000018737 Parkinson disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000009194 climbing Effects 0.000 description 4
- 238000001647 drug administration Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 241000382455 Angelica sinensis Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- RSDOPYMFZBJHRL-UHFFFAOYSA-N Oxotremorine Chemical compound O=C1CCCN1CC#CCN1CCCC1 RSDOPYMFZBJHRL-UHFFFAOYSA-N 0.000 description 2
- 229960004998 acesulfame potassium Drugs 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Agronomy & Crop Science (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种用于改善帕金森综合征的保健饮料,活性成分为蚕豆(带豆荚)提取物以及天然植物混合提取物,两者的比例为(1‑8):1;天然植物混合提取物的组成按重量比如下:天麻10‑15份,黄芪10‑15份,当归5‑10份,川芎2‑3份,厚朴3‑5份,茯苓5‑10份,甘草1‑2份,本发明制备的保健饮料与现有技术相比,增加的天然植物组合提取物与蚕豆(带豆荚)提取物组合后,发挥协同作用,弥补了单一蚕豆类提取物有效成分的功能单一的作用,更适合帕金森人群的保健需要。The invention discloses a health drink for improving Parkinson's syndrome, the active ingredient is broad bean (with pods) extract and natural plant mixed extract, the ratio of the two is (1‑8):1; natural plant mixed The composition of the extract is as follows by weight: 10-15 parts of Tianma, 10-15 parts of Astragalus, 5-10 parts of Angelica, 2-3 parts of Chuanxiong, 3-5 parts of Magnolia officinalis, 5-10 parts of Poria cocos, 1-2 parts of licorice Compared with the prior art, the health drink prepared by the present invention has a synergistic effect after the increased natural plant combination extract is combined with the broad bean (with pods) extract, which makes up for the single function of the active ingredient of the single broad bean extract. It is more suitable for the health care needs of the Parkinson's population.
Description
技术领域Technical Field
本发明为保健品技术技术,具体涉及一种含有蚕豆(带豆荚)提取物的保健饮料及其制备方法。The invention relates to health care product technology, and in particular to a health care beverage containing broad bean (with pods) extract and a preparation method thereof.
背景技术Background Art
近年来,从蚕豆中提取的左旋多巴胺、原花青素以及黄酮类物质的生理活性研究越来越多,其原花色素具有抗氧化、抑菌、抗癌和抗突变等生理活性,黄酮类物质也有降血脂、抗动脉硬化,抗肿瘤、抗骨质疏松等作用,民间也一直有吃蚕豆能缓解帕金森病的习惯。In recent years, there have been more and more studies on the physiological activities of L-dopamine, proanthocyanidins and flavonoids extracted from broad beans. The proanthocyanidins have antioxidant, antibacterial, anti-cancer and anti-mutagenic physiological activities. Flavonoids also have lipid-lowering, anti-atherosclerotic, anti-tumor and anti-osteoporosis effects. People have always had the habit of eating broad beans to relieve Parkinson's disease.
然而单一的蚕豆提取物保健品功效单一,无法提供比较全面的保健功能,本发明加入了多种药食同源的天然物质,通过天然成分的协同作用,扩大的蚕豆提取物保健品的功效范围,给帕金森人群提供了更丰富的选择。However, a single broad bean extract health product has a single effect and cannot provide a relatively comprehensive health function. The present invention adds a variety of natural substances that are both medicinal and edible. Through the synergistic effect of natural ingredients, the efficacy range of broad bean extract health products is expanded, providing Parkinson's patients with more abundant choices.
发明内容Summary of the invention
本发明目的是这样实现的。The object of the present invention is achieved in this way.
一种用于改善帕金森综合征的保健饮料,活性成分为蚕豆(带豆荚)提取物以及天然植物混合提取物。A health drink for improving Parkinson's syndrome, wherein the active ingredients are broad bean (with pod) extract and natural plant mixed extract.
天然植物混合提取物中的植物成分按重量比如下:天麻10-15份,黄芪10-15份,当归5-10份,川芎2-3份,厚朴3-5份,茯苓5-10份,炙甘草1-2份。The plant components in the natural plant mixed extract are as follows by weight: 10-15 parts of Gastrodia elata, 10-15 parts of Astragalus membranaceus, 5-10 parts of Angelica sinensis, 2-3 parts of Chuanxiong, 3-5 parts of Magnolia officinalis, 5-10 parts of Poria cocos, and 1-2 parts of Radix Glycyrrhizae Preparata.
所述含蚕豆(带豆荚)提取物的保健饮料的制作方法如下:The preparation method of the health drink containing broad bean (with pods) extract is as follows:
蚕豆(带豆荚)提取物的制备方法如下:将新鲜蚕豆(带豆荚)筛检后称重,清洗干净后用1-2倍水量煮沸杀青1min,滤去水后进行榨汁,榨汁液中用400目滤布进行过滤。滤液中加入0.01%-0.05%焦亚硫酸钠,0.05-0.2%依地酸二钠,即得蚕豆(含豆荚) 提取物。The preparation method of broad bean (with pods) extract is as follows: fresh broad beans (with pods) are screened and weighed, washed and boiled with 1-2 times the amount of water for 1 minute, filtered to remove the water and then squeezed the juice, and the juice was filtered with a 400-mesh filter cloth. 0.01%-0.05% sodium pyrosulfite and 0.05-0.2% disodium edetate are added to the filtrate to obtain the broad bean (with pods) extract.
其他天然植物混合提取物的制备方法如下:将配方量的天麻、黄芪、当归、川芎、厚朴、茯苓、炙甘草加入提取罐中,加入上述植物总重量的5-10倍量的水,浸泡0.5-1.0 小时,将浸泡后的植物煮沸后开始计时,煎煮2小时放出煮液;再加入植物总量5-10 倍量的食品用水,继续煎煮90min,放出煮液。合并煮液,用纱布过滤,取滤液减压浓缩至密度1.1-1.3的浸膏。The preparation method of other natural plant mixed extracts is as follows: add the formula amount of Gastrodia elata, Astragalus, Angelica sinensis, Chuanxiong, Magnolia officinalis, Poria cocos, and Glycyrrhiza uralensis to the extraction tank, add 5-10 times the total weight of the above plants in water, soak for 0.5-1.0 hours, boil the soaked plants and start timing, boil for 2 hours and release the boiling liquid; then add 5-10 times the total amount of food water for the plants, continue to boil for 90 minutes, and release the boiling liquid. Combine the boiling liquids, filter with gauze, and take the filtrate and decompress and concentrate it to an extract with a density of 1.1-1.3.
取蚕豆(带豆荚)提取物以及其他天然植物混合提取物以一定比例混合,所述比例为(1-8):1,加入0.05%-0.1%安赛蜜,0.05%-0.1%山梨酸钾,经瞬杀后灌装,即得保健品饮料。Broad bean (with pods) extract and other natural plant mixed extracts are mixed in a certain ratio of (1-8):1, 0.05%-0.1% acesulfame potassium and 0.05%-0.1% potassium sorbate are added, and the mixture is instantaneously killed and then filled to obtain a health beverage.
帕金森病属中医“颤症”范畴,本病病位在脑,涉及肝、肾、脾。中医认为本病的发病机理是肝肾亏虚,气血不足,一般采用滋补肝肾,益气养血,熄风止颤的方法。Parkinson's disease belongs to the category of "tremor syndrome" in traditional Chinese medicine. The disease is located in the brain and involves the liver, kidney and spleen. Traditional Chinese medicine believes that the pathogenesis of this disease is liver and kidney deficiency and insufficient qi and blood. Generally, the method of nourishing the liver and kidney, replenishing qi and blood, and extinguishing wind and stopping tremor is adopted.
本发明中,天麻为君药,天麻具有息风止痉,平抑肝阳,祛风通络的功效,黄芪为臣药,黄芪补气固表,托毒排脓,厚朴、茯苓和川芎为佐药,茯苓健运脾土,助后天气血化生,厚朴理气宽肠,防气机壅滞,川芎活血行气,能开能散,上行头目,旁达四肢,下行血海,能畅行气血。三者合力使气血行,脉络通。炙甘草为使药,调和诸药,补脾益气。此天然植物组合提取物与蚕豆(带豆荚)提取物组合后,发挥协同作用,弥补了单一蚕豆类提取物有效成分的功能单一的作用,更适合帕金森人群的保健需要。In the present invention, Gastrodia elata is the main drug, which has the effects of calming wind and stopping spasm, calming liver yang, and dispelling wind and unblocking collaterals. Astragalus is the assistant drug, which invigorates qi and consolidates the exterior, supports toxins and discharges pus. Magnolia officinalis, Poria cocos and Chuanxiong are adjuvant drugs. Poria cocos strengthens the spleen and earth, helps the acquired qi and blood to form, Magnolia officinalis regulates qi and widens the intestines, prevents qi stagnation, and Chuanxiong activates blood circulation and promotes qi, can open and disperse, ascends to the head, reaches the limbs, descends to the sea of blood, and can promote qi and blood. The three work together to make qi and blood flow and the meridians unblocked. Radix Glycyrrhizae Preparata is the guiding drug, which harmonizes various drugs and invigorates the spleen and replenishes qi. After the natural plant combination extract is combined with the broad bean (with pods) extract, a synergistic effect is exerted, which makes up for the single function of the effective ingredient of the single broad bean extract, and is more suitable for the health care needs of Parkinson's disease population.
具体实施方式DETAILED DESCRIPTION
为更好的说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步说明。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below in conjunction with specific embodiments.
实施例1:保健品饮料的制备Example 1: Preparation of health beverage
蚕豆(带豆荚)提取物的制备方法如下:将新鲜蚕豆(带豆荚)筛检后称重16.3kg,清洗干净后用1-2倍水量煮沸杀青1min,滤去水后进行榨汁,榨汁液中用400目滤布进行过滤。滤液中加入0.01%焦亚硫酸钠,0.2%依地酸二钠,即得蚕豆(含豆荚)提取物。The preparation method of broad bean (with pods) extract is as follows: fresh broad beans (with pods) are screened and weighed to 16.3 kg, washed and boiled with 1-2 times the amount of water for 1 minute, filtered to remove the water and then squeezed the juice, and the juice was filtered with a 400-mesh filter cloth. 0.01% sodium pyrosulfite and 0.2% disodium edetate were added to the filtrate to obtain the broad bean (with pods) extract.
其他天然植物混合提取物的制备方法如下:将天麻12份、黄芪12份、当归8份、川芎2份、厚朴3份、茯苓5份、炙甘草1份加入提取罐中,加入上述植物总重量的8 倍量的水,浸泡0.5小时,将浸泡后的植物煮沸后开始计时,煎煮2小时放出煮液;再加入植物总量5倍量的食品用水,继续煎煮90min,放出煮液。合并煮液,用纱布过滤,取滤液减压浓缩至25摄氏度时相对密度为1.17的浸膏。The preparation method of other natural plant mixed extracts is as follows: add 12 parts of Gastrodia elata, 12 parts of Astragalus, 8 parts of Angelica sinensis, 2 parts of Chuanxiong, 3 parts of Magnolia officinalis, 5 parts of Poria cocos, and 1 part of Glycyrrhiza uralensis to an extraction tank, add 8 times the total weight of the above plants in water, soak for 0.5 hours, boil the soaked plants and start timing, boil for 2 hours and release the boiled liquid; then add 5 times the total amount of food water for the plants, continue to boil for 90 minutes, and release the boiled liquid. Combine the boiled liquids, filter with gauze, and take the filtrate and concentrate it under reduced pressure to an extract with a relative density of 1.17 at 25 degrees Celsius.
取蚕豆(带豆荚)提取物4份,其他天然植物混合提取物1份,加入0.05%安赛蜜,0.05%山梨酸钾,130℃瞬杀30s后灌装成50ml/瓶,即得含蚕豆(带豆荚)提取的保健品饮料。Take 4 parts of broad bean (with pods) extract and 1 part of other natural plant mixed extracts, add 0.05% acesulfame potassium and 0.05% potassium sorbate, kill at 130°C for 30 seconds and then fill into 50ml/bottle to obtain a health drink containing broad bean (with pods) extract.
实施例2:药效学实验Example 2: Pharmacodynamics Experiment
取成年健康小鼠30只,分空白组,模型组,试验组3组,每组10只。Thirty adult healthy mice were divided into three groups: blank group, model group, and experimental group, with 10 mice in each group.
实验分组:取成年小鼠30只,分3组,每组10只,空白对照组(生理盐水灌胃1-21d,生理盐水腹腔注射22-29d),模型组(生理盐水灌胃1-21d,MPTP(注:MPTP为1- 甲基-4-苯基-1,2,3,6-四氢吡啶,下同。)22-29d),给药组(本发明的保健饮料1-21d,, MPTP 22-29d)Experimental grouping: 30 adult mice were divided into 3 groups, 10 mice in each group, blank control group (normal saline gavage for 1-21 days, normal saline intraperitoneal injection for 22-29 days), model group (normal saline gavage for 1-21 days, MPTP (Note: MPTP is 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, the same below) for 22-29 days), drug administration group (health drink of the present invention for 1-21 days, MPTP for 22-29 days)
给药量及给药方式:生理盐水(灌胃/腹腔注射):30mg/kg/dDosage and administration method: Normal saline (oral gavage/intraperitoneal injection): 30 mg/kg/d
保健品饮料(灌胃):1ml/kg,饮料为实施例1制备。Health care beverage (intragastric administration): 1 ml/kg, the beverage was prepared as in Example 1.
MPTP(腹腔注射):30mg/kg/dMPTP (intraperitoneal injection): 30 mg/kg/day
给药频率:一天一次Dosing frequency: Once a day
行为学方法检测:Behavioral testing methods:
爬杆实验:取直径1cm、高50cm、顶部有一直径3cm木球的光滑木杆。测试时将被测小鼠置于软木小球上,记录小鼠爬到杆底所需要的时间并做统计学分析。在给药第 21天测定所有小鼠爬杆时间,并在第29天给药1h后,再次测定其爬杆时间。Pole climbing test: Take a smooth wooden pole with a diameter of 1 cm, a height of 50 cm, and a wooden ball with a diameter of 3 cm on the top. During the test, the mice were placed on the cork ball, and the time required for the mice to climb to the bottom of the pole was recorded and statistically analyzed. The climbing time of all mice was measured on the 21st day of drug administration, and the climbing time was measured again 1 hour after drug administration on the 29th day.
转轴实验:将小鼠置于转棒上,测试小鼠从转棒开始旋转到从转棒上掉落的时间。在给药第21天测定所有小鼠转轴时间,并在第29天给药1h后,测定其转轴时间。Rotating axis test: Place mice on a rotating rod and test the time from the start of the rotation of the rod to the time the mice fall off the rod. The rotating axis time of all mice was measured on the 21st day of administration, and on the 29th day, 1 hour after administration, their rotating axis time was measured.
抓力实验:将受试小鼠放置于拉力仪上,抓住小鼠尾部,向后直线拉拽,记录抓力数据。在给药第21天测定所有小鼠抓力大小,并在第29天给药后,再次测定其拉力。Grip strength test: Place the test mice on a tensile tester, grab the tail of the mouse, pull it backward in a straight line, and record the grip strength data. Measure the grip strength of all mice on the 21st day of administration, and measure the pulling force again on the 29th day after administration.
药效结果:Efficacy results:
由数据可知:通过小鼠帕金森模型,给药组能够明显增加模型组小鼠爬杆时间、转轴时间,增大小鼠拉力。表明本保健品饮料对于帕金森模型小鼠具有明显的治疗效果。The data show that: through the mouse Parkinson's model, the drug group can significantly increase the climbing time and rotation time of the model group mice, and increase the pulling force of the mice. This shows that the health drink has a significant therapeutic effect on Parkinson's model mice.
实施例3:药效学实验Example 3: Pharmacodynamics Experiment
取成年健康小鼠30只,分空白组,模型组,试验组3组,每组10只。Thirty healthy adult mice were divided into three groups: blank group, model group, and experimental group, with 10 mice in each group.
实验分组:取成年小鼠30只,分3组,每组10只,空白对照组(生理盐水灌胃1-21d,生理盐水腹腔注射22-21d),模型组1(生理盐水灌胃1-21d,槟榔碱造模),模型组 2(生理盐水灌胃1-21d,氧化震颤素造模),给药组(本发明的保健饮料1-21d,槟榔碱造模)。Experimental groups: 30 adult mice were divided into 3 groups, 10 mice in each group, blank control group (normal saline gavage for 1-21 days, normal saline intraperitoneal injection for 22-21 days), model group 1 (normal saline gavage for 1-21 days, arecoline modeling), model group 2 (normal saline gavage for 1-21 days, oxotremorine modeling), drug administration group (health drink of the present invention for 1-21 days, arecoline modeling).
给药量及给药方式:生理盐水(灌胃/腹腔注射):30mg/kg/dDosage and administration method: Normal saline (oral gavage/intraperitoneal injection): 30 mg/kg/d
保健品饮料(灌胃):1ml/kg,饮料为实施例1制备。Health care beverage (intragastric administration): 1 ml/kg, the beverage was prepared as in Example 1.
槟榔碱(腹腔注射):30mg/kg/dArecoline (intraperitoneal injection): 30 mg/kg/day
氧化震颤素(腹腔注射):0.30mg/kg/dOxotremorine (intraperitoneal): 0.30 mg/kg/day
给药频率:一天一次Dosing frequency: Once a day
行为学方法检测:记录每只小鼠自肉眼明显可见的肌肉震颤产生至消失所需的时间为震颤持续时间。Behavioral detection: The time required for each mouse from the onset of muscle tremor that is clearly visible to the naked eye to its disappearance is recorded as the tremor duration.
药效结果:Efficacy results:
由数据可知:小鼠腹腔注射槟榔碱和氧化震颤素后出现明显的震颤,槟榔碱组的震颤时间更长。但是提前给与本发明制备的保健饮料的给药组均有明显缩短震颤的持续时间,表明本发明的保健饮料对模拟帕金森形成的震颤有明显的改善作用。对槟榔碱造模形成的震颤以及氧化震颤素造模形成的震颤,均有缓解作用,表明本保健品饮料对于帕金森模型小鼠具有明显的治疗效果。The data show that mice developed obvious tremors after intraperitoneal injection of arecoline and oxidotremorine, and the tremor duration of the arecoline group was longer. However, the groups given the health drink prepared by the present invention in advance all had significantly shortened tremor duration, indicating that the health drink of the present invention has a significant improvement effect on the tremor formed by simulating Parkinson's disease. It has a relieving effect on the tremor formed by the arecoline modeling and the tremor formed by the oxidotremorine modeling, indicating that the health drink has a significant therapeutic effect on Parkinson's disease model mice.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111438368.2A CN116172196A (en) | 2021-11-28 | 2021-11-28 | A health drink containing broad bean (with pods) extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111438368.2A CN116172196A (en) | 2021-11-28 | 2021-11-28 | A health drink containing broad bean (with pods) extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116172196A true CN116172196A (en) | 2023-05-30 |
Family
ID=86440973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111438368.2A Pending CN116172196A (en) | 2021-11-28 | 2021-11-28 | A health drink containing broad bean (with pods) extract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116172196A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037581A (en) * | 2001-11-06 | 2003-05-14 | 이태숙 | manufacturing process of healthy drink |
CN1739743A (en) * | 2005-01-19 | 2006-03-01 | 广东众生药业股份有限公司 | Medicine for treating Parkinson's disease and Parkinson's syndrome and preparation method thereof |
CN102934799A (en) * | 2012-11-16 | 2013-02-20 | 南京艾德凯腾生物医药有限责任公司 | Healthcare product containing broad bean extracts and application of healthcare product |
KR20140018597A (en) * | 2012-08-02 | 2014-02-13 | (주)아모레퍼시픽 | Composition for antiinflammation containing extract of soybean pod |
EP3225245A1 (en) * | 2016-03-29 | 2017-10-04 | Ramon Cacabelos Garcia | Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases |
US10300100B1 (en) * | 2018-09-27 | 2019-05-28 | King Saud University | Extract of Vicia faba beans |
-
2021
- 2021-11-28 CN CN202111438368.2A patent/CN116172196A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030037581A (en) * | 2001-11-06 | 2003-05-14 | 이태숙 | manufacturing process of healthy drink |
CN1739743A (en) * | 2005-01-19 | 2006-03-01 | 广东众生药业股份有限公司 | Medicine for treating Parkinson's disease and Parkinson's syndrome and preparation method thereof |
KR20140018597A (en) * | 2012-08-02 | 2014-02-13 | (주)아모레퍼시픽 | Composition for antiinflammation containing extract of soybean pod |
CN102934799A (en) * | 2012-11-16 | 2013-02-20 | 南京艾德凯腾生物医药有限责任公司 | Healthcare product containing broad bean extracts and application of healthcare product |
EP3225245A1 (en) * | 2016-03-29 | 2017-10-04 | Ramon Cacabelos Garcia | Bioactive extract obtained from vicia faba and its use in the treatment and/or prevention of neurodegenerative diseases |
US10300100B1 (en) * | 2018-09-27 | 2019-05-28 | King Saud University | Extract of Vicia faba beans |
Non-Patent Citations (2)
Title |
---|
"从蚕豆荚皮中提取左旋多巴", 卫生研究, no. 01, pages 6 - 8 * |
张希廉;田军彪;耿百乐;石玫;顾平;: "抗颤宁方对帕金森病大鼠行为学及脂质过氧化的影响", 河北中医, no. 03, pages 441 - 443 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106310120A (en) | Wide-spectrum traditional Chinese medicine composition water agent and preparation method thereof | |
CN106689933A (en) | Natural component extract enriched alcohol effect dispelling liver-protection drink and preparation method thereof | |
CN107853517B (en) | A kind of Chinese medicinal beverage for refreshing and anti-fatigue and preparation method thereof | |
CN101961401B (en) | A kind of compound traditional Chinese medicine composition with effect of losing weight, lowering fat and invigorating spleen | |
CN103689152A (en) | Herbal tea for tonifying kidney and removing heat from liver and preparation method thereof | |
CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
CN112915181B (en) | A kind of Qi and Fuyuan paste formula and its application | |
CN105878812A (en) | Hangover-relieving beverage produced using Camellia chrysantha and Caulis dendrobii and production method thereof | |
CN104474251B (en) | Composition and its preparation and the application of function are consolidated with brain tonic | |
CN108143977A (en) | A kind of multi-function health-care medicinal liquor | |
CN105833011A (en) | Healthcare medicinal liquor | |
CN116172196A (en) | A health drink containing broad bean (with pods) extract | |
CN107890521A (en) | A kind of Chinese medicine composition of liver protection and eyesight and its preparation method of pill | |
CN103623109B (en) | Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof | |
CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
CN105616874A (en) | Liver cancer treatment pharmaceutical composition and preparation method thereof | |
CN104784491A (en) | Traditional Chinese medicine preparation for treating salpingitis of laying hens and preparation method thereof | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN104223062B (en) | Root bark of Chinese wolf-berry health care oral liquid of a kind of reducing pressure and sugar and preparation method thereof | |
CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
CN108186821A (en) | A kind of Chinese medicine composition for treating nervous headache and its preparation method and application | |
CN109106842B (en) | A medicine for stopping smoking and its preparation method | |
CN105250749A (en) | Traditional Chinese medicine for treating thyroid adenoma and preparation method thereof | |
CN117085089A (en) | Pharmaceutical composition for treating Alzheimer disease and preparation method thereof | |
CN105395791A (en) | Traditional Chinese medicine for painless induced abortion surgery anesthesia and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20230530 |
|
WD01 | Invention patent application deemed withdrawn after publication |